Evidence map›Paper›PMID 38627421›Full record

ArticleScientific reports2024

Exploring fetal brain tumor glioblastoma symptom verification with self organizing maps and vulnerability data analysis.

Suresh Kumar Natarajan, Jayanthi S, Sandeep Kumar Mathivanan, Hariharan Rajadurai, Benjula Anbu Malar M B, Mohd Asif Shah

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Suresh Kumar NatarajanSchool of Computer Science and Engineering, JAIN (Deemed-to-be University), Ramanagara, India.
Jayanthi SDepartment of Information Technology, Guru Nanak Institute of Technology, Ibrahimpatnam, Hyderabad, Telangana, India.
Sandeep Kumar MathivananSchool of Computer Science and Engineering, Galgotias University, Greater Noida, 203201, Uttar Pradesh, India.
Hariharan RajaduraiSchool of Computing Science and Engineering, VIT Bhopal University, Bhopal-Indore Highway Kothrikalan, Sehore, MP, India.
Benjula Anbu Malar M BSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Mohd Asif ShahKebri Dehar University, Kebri Dehar, 250, Somali, Ethiopia. drmohdasifshah@kdu.edu.et.
Barkatullah University · INGalgotias University · INGuru Nanak Institutions · INJain University · INKebri Dehar UniversityVellore Institute of Technology University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor glioblastoma is a disease that is caused for a child who has abnormal cells in the brain, which is found using MRI "Magnetic Resonance Imaging" brain image using a powerful magnetic field, radio waves, and a computer to produce detailed images of the body's internal structures it is a standard diagnostic tool for a wide range of medical conditions, from detecting brain and spinal cord injuries to identifying tumors and also in evaluating joint problems. This is treatable, and by enabling the factor for happening, the factor for dissolving the dead tissues. If the brain tumor glioblastoma is untreated, the child will go to death; to avoid this, the child has to treat the brain problem using the scan of MRI images. Using the neural network, brain-related difficulties have to be resolved. It is identified to make the diagnosis of glioblastoma. This research deals with the techniques of max rationalizing and min rationalizing images, and the method of boosted division time attribute extraction has been involved in diagnosing glioblastoma. The process of maximum and min rationalization is used to recognize the Brain tumor glioblastoma in the brain images for treatment efficiency. The image segment is created for image recognition. The method of boosted division time attribute extraction is used in image recognition with the help of MRI for image extraction. The proposed boosted division time attribute extraction method helps to recognize the fetal images and find Brain tumor glioblastoma with feasible accuracy using image rationalization against the brain tumor glioblastoma diagnosis. In addition, 45% of adults are affected by the tumor, 40% of children and 5% are in death situations. To reduce this ratio, in this study, the Brain tumor glioblastoma is identified and segmented to recognize the fetal images and find the Brain tumor glioblastoma diagnosis. Then the tumor grades were analyzed using the efficient method for the imaging MRI with the diagnosis result of partially high. The accuracy of the proposed TAE-PIS system is 98.12% which is higher when compared to other methods like Genetic algorithm, Convolution neural network, fuzzy-based minimum and maximum neural network and kernel-based support vector machine respectively. Experimental results show that the proposed method archives rate of 98.12% accuracy with low response time and compared with the Genetic algorithm (GA), Convolutional Neural Network (CNN), fuzzy-based minimum and maximum neural network (Fuzzy min-max NN), and kernel-based support vector machine. Specifically, the proposed method achieves a substantial improvement of 80.82%, 82.13%, 85.61%, and 87.03% compared to GA, CNN, Fuzzy min-max NN, and kernel-based support vector machine, respectively.

Indexed as

Brain NeoplasmsGlioblastomaAdultAlgorithmsBrainChildHumansImage Processing, Computer-AssistedFetal brain tumorGlioblastomaMax rationalizingMin rationalizingSegmentationTime attribute extraction

Identifiers

PMID38627421
PMCPMC11522281
OpenAlexW4394854226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.